Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-30 5:07 pm Purchase | 2023-03-28 | 13D | ACRIVON THERAPEUTICS INC ACRV | RA CAPITAL MANAGEMENT L.P. | 4,817,359 22.000% | 3,917 (+0.08%) | Filing History |
| 2023-03-30 5:02 pm Purchase | 2023-03-28 | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 12,876,898 18.000% | 6,717,844 (+109.07%) | Filing History |
| 2023-03-29 5:14 pm Purchase | 2023-03-27 | 13D | DICE THERAPEUTICS INC DICE | RA CAPITAL MANAGEMENT L.P. | 7,660,615 16.100% | 811,704 (+11.85%) | Filing History |
| 2023-03-27 5:00 pm Purchase | 2023-03-15 | 13G | CUREVAC N V CUREVAC N V IN CON CVAC | RA CAPITAL MANAGEMENT L.P. | 12,245,955 5.500% | 12,245,955 (New Position) | Filing History |
| 2023-03-20 4:30 pm Purchase | 2023-03-10 | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 18,564,300 9.990% | 18,564,300 (New Position) | Filing History |
| 2023-02-27 4:57 pm Sale | 2023-02-23 | 13G | IMARA INC IMRA | RA CAPITAL MANAGEMENT L.P. | 2,122,465 5.200% | -1,128,259 (-34.71%) | Filing History |
| 2023-02-24 4:30 pm Purchase | 2023-02-14 | 13D | MINERALYS THERAPEUTICS INC MLYS | RA CAPITAL MANAGEMENT L.P. | 3,180,920 7.800% | 3,180,920 (New Position) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | THIRD HARMONIC BIO INC THRD | RA CAPITAL MANAGEMENT L.P. | 534,687 1.300% | -2,941,000 (-84.62%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 2,249,421 9.900% | 762,950 (+51.33%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | RA CAPITAL MANAGEMENT L.P. | 5,199,746 9.990% | 1,689,643 (+48.14%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | GH RESH PLC SHS GHRS | RA CAPITAL MANAGEMENT L.P. | 4,898,373 9.400% | 2,054,616 (+72.25%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | KINNATE BIOPHARMA INC KNTE | RA CAPITAL MANAGEMENT L.P. | 4,264,144 9.700% | 671,092 (+18.68%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,516,067 9.800% | 645,000 (+13.24%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | IMMUNOGEN INC IMGN | RA CAPITAL MANAGEMENT L.P. | 22,075,158 9.990% | -87,800 (-0.40%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | 5:01 ACQUISITION CORP FVAM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | PARDES BIOSCIENCES INC PRDS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,431,901 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | SYNLOGIC INC SYBX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -444,444 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ADICET BIO INC ACET | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -147,772 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | MAGENTA THERAPEUTICS INC MGTA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,588,081 (Position Closed) | Filing History |